Logo-ipp

Read This Article

Article History

Submitted: 01 Aug 2020
Accepted: 08 Aug 2020
ePublished: 12 Aug 2020

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

Immunopathol Persa. 2021;7(2): e12.
doi: 10.34172/ipp.2021.12

Scopus ID: 85102581659
  Abstract View: 11027
  PDF Download: 10631

Editorial

Controversy with bromhexine in COVID-19; where we stand

Ramin Tolouian 1* ORCID logo, Zuber D. Mulla 2 ORCID logo

1 Division of Nephrology, University of Arizona, Tucson, AZ, USA
2 Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA, and Julia Jones Matthews Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX, USA
*Corresponding Author: Correspondence to Prof. Ramin Tolouian, Email; , Email: Ramin.tolouian@va.gov
Citation: Tolouian R , Mulla ZD. Controversy with bromhexine in COVID-19; where we stand. Immunopathol Persa. 2021;7(2):e12. DOI:10.34172/ ipp.2021.12.
First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.

Full Text View:

Your browser does not support the canvas element.